Propanc Biopharma (PPCB) Cash & Equivalents (2015 - 2026)
Propanc Biopharma's Cash & Equivalents came in at $832,006 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $12,088 a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Cash & Equivalents (2015 - 2026) Analysis & Trends
Going back to fiscal Q4 2015, Propanc Biopharma's Cash & Equivalents data covers 42 quarters.
- Cash & Equivalents carries a five-year compound annual growth rate of 226.1% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $12,088 in FY2025 (-42.7%), $21,085 in FY2024 (+109.9%), $10,047 in FY2023 (+147.0%) and $4,067 in FY2022 (+80.4%).
- The fiscal Q4 2026 figure represents the highest quarterly Cash & Equivalents since fiscal Q3 2016.
- Year-over-year, Cash & Equivalents increased in two of the last four quarters, with growth averaging 158.4%.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q3 2022 (growth of 827.2%), and the weakest in fiscal Q3 2024 (a decline of 93.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | 832,006.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 832,006.00 |
| Dec 31, 2025 | 561,237.00 |
| Sep 30, 2025 | 602,737.00 |
| Jun 30, 2025 | 12,088.00 |
| Mar 31, 2025 | 50,760.00 |
| Dec 31, 2024 | 14,633.00 |
| Sep 30, 2024 | 9,268.00 |
| Jun 30, 2024 | 21,085.00 |
| Mar 31, 2024 | 6,222.00 |
| Dec 31, 2023 | 71,650.00 |
| Sep 30, 2023 | 6,625.00 |
| Jun 30, 2023 | 10,047.00 |
| Mar 31, 2023 | 93,241.00 |
| Dec 31, 2022 | 24,476.00 |
| Sep 30, 2022 | 19,396.00 |
| Jun 30, 2022 | 4,067.00 |
| Mar 31, 2022 | 133,885.00 |
| Dec 31, 2021 | 73,616.00 |
| Sep 30, 2021 | 45,817.00 |
| Jun 30, 2021 | 2,255.00 |
API Access
Propanc Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();